Dr Andrew Kaunitz disputes the recent findings from a Danish breast cancer risk study that primarily studied women in a lower-risk group.

You might have to prescribe older diabetes drugs to some patients so that they will be able to maintain treatment.

This large-scale study is an important contribution to the literature, notes Dr JoAnn Manson, but should it change practice?

Dr Jonathan Kay reviews three studies evaluating three different withdrawal strategies for patients with arthritis, from the ACR/ARHP Annual Meeting.

The American Heart Association sessions featured two new analyses from the FOURIER trial, which prompted a discussion on the cost-effectiveness of PCSK9 inhibitor lipid-lowering therapy.

Dr Jonathan Kay provides an overview of news and views on biosimilars to be presented at ACR 2017.

Drs Beckman and Soffin from Hospital for Special Surgery explain safe and synergistic methods of controlling pain.

The FreeStyle Libre, a newly approved device for continuous glucose monitoring, is a big advance for people with diabetes who want to avoid finger sticks, says Dr Anne Peters.

Combination treatments are escalating already urgent questions about the cost and value of new cancer drugs.

Benzodiazepines could increase mortality rates, especially in the elderly, but the latest research might suggest otherwise.